Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Sales Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Net Sales Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Net Sales Growth(%) 6.089.3916.685.97-5.32

What is the latest Net Sales Growth ratio of AUROBINDO PHARMA ?

The latest Net Sales Growth ratio of AUROBINDO PHARMA is 6.08 based on Mar2026 Consolidated results.
Year Net Sales Growth
Mar20266.08
Mar20259.39
Mar202416.68
Mar20235.97
Mar2022-5.32

How is Net Sales Growth of AUROBINDO PHARMA Trending?

Years Net Sales Growth % Change
Mar2026 6.08
-35.25
Mar2025 9.39
-43.71
Mar2024 16.68
179.40
Mar2023 5.97
Positive
Mar2022 -5.32 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Net Sales Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹98,807.7 Cr 3.1% 6.9% 57.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,196.0 Cr 1.8% -1.7% 14.6% Stock Analytics
DIVIS LABORATORIES ₹250,390.0 Cr 2.6% 9.8% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,967.0 Cr 2.4% -0.5% 36% Stock Analytics
CIPLA ₹111,888.0 Cr 1.8% -3.7% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹100,329.0 Cr 4.5% 1.8% -10% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

3.1%

6.9%

57.9%

SENSEX

0.1%

-2.7%

-8.6%


You may also like the below Video Courses